Baird Medical Investment Holdings LtdBDMD

NasdaqHealthcareSurgical & Medical Instruments & Apparatus
Price (close)
$0.77
Market cap
$24.5M
P/E
—
Revenue (FY)
$22.5M
Net income
-$27.3M
Dividend yield
—
1-year total return
-67.1%
Net margin
-121.0%
Revenue growth
-39.2%
Debt / equity
0.28x

What Baird Medical Investment Holdings Ltd does.

We are a specialized healthcare innovator dedicated exclusively to thyroid related diseases. By combining extensive clinical understanding with cutting-edge technologies, we aim to transform traditional thyroid treatment through intelligent, non-invasive solutions. Our mission is to build an ecosystem that spans the entire treatment process, spanning from early screening and diagnosis to robotic-assisted ablation and posttreatment care.

Our core strengths lie in our successful development and commercialization of the thyroid microwave ablation system, as well as our active R&D pipeline featuring AI-integrated robotic systems. Our approach integrates hardware innovation, software intelligence and a comprehensive system mindset, positioning us to lead in a highly specialized and globally significant market.

What set us unique are our category focus, our full-stack technology strategy and our proven regulatory and commercial execution. Backed by a vision to deliver safer, faster, and more accurate thyroid care to patients worldwide, we are positioned to become the first global platform company dedicated to precision thyroid health.

Revenue and profit, by fiscal year.

Fiscal year20212022202320242025
Revenue—$35.1M$31.5M$37.0M$22.5M
Net income—$12.6M$10.5M$12.5M-$27.3M
Free cash flow—-$5.4M-$3.7M-$9.2M-$1.4M

More on BDMD.

Figures from Baird Medical Investment Holdings Ltd's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.